By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS


Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Maxygen, Inc. 

Intergen Company 





Company News
FDA Staff Questions Usefulness of Novo Nordisk A/S (NVO)’s Diabetes Drug Combo 5/23/2016 7:51:22 AM
FDA Questions Study Findings, Practicality of Novo Nordisk A/S (NVO)'s Diabetes Drug Ideglira 5/23/2016 6:13:28 AM
Novo Nordisk A/S (NVO), Chip Ganassi Racing Teams And Charlie Kimball Honor The Diabetes Community With The No. 42 Tresiba (Insulin Degludec Injection 200 Units/Ml) Chevrolet At The 100th Running Of The Indianapolis 500 5/16/2016 9:10:12 AM
Great Place to Work and Fortune Name Novo Nordisk A/S (NVO) As One Of The Country's Best Workplaces For Giving Back 4/26/2016 3:36:04 PM
As Part of Worldwide Expansion, Novo Nordisk A/S (NVO) Spends 100 Million Euros to Build in France 4/21/2016 6:57:01 AM
Novo Nordisk A/S (NVO) Marks World Hemophilia Day By Raising Awareness Of Bleeding Disorders In The Community And Beyond 4/15/2016 8:32:55 AM
The 5 Best Life Science Companies with Great Perks and Work Culture 4/6/2016 11:20:25 AM
Novo Nordisk A/S (NVO) Release: Semaglutide Demonstrated Superior Improvements In Glycemic Control Vs Placebo In Adults With Type 2 Diabetes 4/4/2016 9:18:57 AM
Novo Nordisk A/S (NVO) Release: Semaglutide Demonstrated Superior Improvements In Glycemic Control Vs Placebo In Adults With Type 2 Diabetes 4/4/2016 9:11:41 AM
Novo Nordisk A/S (NVO) Release: Saxenda (liraglutide [rDNA origin] Injection) Demonstrated Significant Improvements In Cardiometabolic Risk Factors Over Three Years Compared With Placebo 4/4/2016 8:34:38 AM
12345678910...
//-->